Alger AI Enablers & Adopters ETF

ALAI · ETF

$42.15−$0.11 (−0.26%)TodayMarket closed ·
Prev close $42.26

About ALAI

ALAI was created on 2024-04-05 by Alger. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 1561.6m in AUM and 67 holdings. ALAI is actively managed, investing in firms benefiting from developing, integrating or enabling artificial intelligence (AI) technology. The fund seeks long-term capital growth through fundamental research.

Issuer
Alger
Expense ratio
0.58%
Assets under management
$2.42B
Inception
Apr 5, 2024
Asset class
Equity
Website
alger.com

ALAI key statistics

Price-earnings ratio
0.00
Average volume
74.46K
Volume
35.58K
Open price
$42.10
High today
$42.53
Low today
$41.96
52 Week high
$48.36
52 Week low
$30.85

Alger AI Enablers & Adopters ETF (ALAI) at a glance

Alger AI Enablers & Adopters ETF (ALAI) last traded at $42.15, with a price-to-earnings ratio of 0.00.

Today the fund has traded between $41.96 and $42.53. The current price is 0.5% above the day's low and 0.9% below its high.

Volume so far is 35.58K shares, below the average of 74.46K shares a day.

Over the past year Alger AI Enablers & Adopters ETF has ranged from $30.85 to $48.36, and now sits 65% of the way up that range.

ALAI news

  • Chandrima Sanyal

    AI ETFs Hit 52-Week Highs—But The Math Just Doesn't Add Up

  • Chandrima Sanyal

    Risk-On Revival: Growth-Themed ETFs Hit 52-Week Highs As Market Calms Down

  • Lekha Gupta

    Global-E Soars: Q3 Sales Surge 32%, FY24 Outlook Raised Amid GMV Boom

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.